Skip to main content

Market Overview

Tickers

Articles

Keywords

Search by keyword...
googlecse

Press Releases

05/30/2026 - 11:29pm
Solana Unchained Outlines Fixed-Supply Utility Architecture and AI Tool Hub Ahead of Late May Public Allocation Launch
05/30/2026 - 10:59pm
Procolored X one Kickstarter Campaign Surpasses $860,000, Demonstrating Strong Demand for Desktop Hybrid UV Printing and Laser Production
05/30/2026 - 10:45pm
As Global Markets Discover Elektros, Microcap and Penny Stock Investors Are Beginning To Take Notice of a Growing EV Patent Technology and Lithium Mining Company
05/30/2026 - 10:33pm
Golden Goblet Competition Lineup Announced: Spotlight on the 2026 Contenders
05/30/2026 - 10:15pm
SIX FLAGS FIESTA TEXAS UNLEASHES WEREWOLF GORGE, THE WORLD'S LONGEST FAMILY LAUNCH ROLLER COASTER
05/30/2026 - 10:13pm
ROSEN, HIGHLY REGARDED INVESTOR COUNSEL, Encourages Veritone, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VERI
05/30/2026 - 10:02pm
Cook County Treasurer Maria Pappas' Historic Property Tax Sale Reform Legislation Passes in Illinois General Assembly
05/30/2026 - 10:00pm
Global EV Charging Patent Update: Elektros Inc. Continues To Advance and Protect Its Intellectual Property as EV Infrastructure Opportunities Expand Worldwide
05/30/2026 - 9:22pm
James Altucher Just Released a Free Presentation He Says Could Be the Most Important 30 Minutes You Watch Before June
05/30/2026 - 9:15pm
Global Microcap Investors Are Discovering a Rare Diamond in the Rough
05/30/2026 - 8:30pm
Crypto News Today: AlphaPepe Hits $1.38M Raised While Bitcoin Price Prediction Targets $250K
05/30/2026 - 8:09pm
Dizal Presents Positive NSCLC Data for Fourth-Generation EGFR TKI DZD6008 and Golidocitinib in Combination with Anti-PD-1 at ASCO 2026
05/30/2026 - 8:00pm
Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC Published in The Lancet
05/30/2026 - 7:46pm
Pompa Program Surpasses 1,300 Trustpilot Ratings with 4.7/5 Star Average
05/30/2026 - 7:45pm
Global Times: Chinese artisan weaves Zhuang brocade into World Cup
05/30/2026 - 7:44pm
Global Times: At 80, award winning illustrator Cai Gao still draws inspiration from childhood
05/30/2026 - 7:36pm
Media Update on Temporary Border Measures in Response to the Ebola Disease Outbreak
05/30/2026 - 7:14pm
Alley Cat Allies Continues to Protect the Cats of the Paseo del Morro and Collaborates with Puerto Rico Leaders
05/30/2026 - 6:52pm
GOSS DEADLINE NOTICE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Gossamer Bio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 1 Deadline in Securities Class Action – GOSS
05/30/2026 - 6:36pm
STLA Deadline: STLA Investors with Losses in Excess of $100K Have Opportunity to Lead Stellantis N.V. Securities Fraud Lawsuit
05/30/2026 - 6:25pm
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Zillow Group, Inc. Investors to Inquire About Securities Class Action Investigation - Z, ZG
05/30/2026 - 6:23pm
B&W DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Babcock & Wilcox Enterprises, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - BW
05/30/2026 - 6:22pm
MEDPACE DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Medpace Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 8 Deadline in Securities Class Action - MEDP
05/30/2026 - 6:13pm
National Champions are Honoured at the Closing Ceremony of the Skills Canada National Competition 2026, in Toronto
05/30/2026 - 5:31pm
SES AI Corporation Deadline: SES Investors with Losses in Excess of $100K Have Opportunity to Lead SES AI Corporation Securities Fraud Lawsuit Filed by The Rosen Law Firm
05/30/2026 - 5:25pm
UPST DEADLINE NOTICE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Upstart Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 8 Deadline in Securities Class Action – UPST
05/30/2026 - 5:24pm
ASCO 2026: Bayer Shares New Findings for NUBEQA® (darolutamide) Regarding Cognitive Decline in Men with Advanced Prostate Cancer Compared to Enzalutamide in Phase II ARACOG Head-to-Head Trial
05/30/2026 - 5:16pm
ThinkCareBelieve: Week 71 of the Trump Administration 2.0
05/30/2026 - 5:07pm
NUAI Deadline: NUAI Investors with Losses in Excess of $100K Have Opportunity to Lead New Era Energy & Digital, Inc. Securities Fraud Lawsuit
05/30/2026 - 5:00pm
Guerra Wealth Advisors Invites South Florida Community to Join the St. Jude Walk Miami as a Champion Sponsor
05/30/2026 - 4:25pm
ROSEN, LEADING INVESTOR COUNSEL, Encourages Sportradar Group AG Investors to Secure Counsel Before Important Deadline in Securities Class Action - SRAD
05/30/2026 - 4:15pm
AdvisorVault Adds Social Media Archiving to its Consolidated D3P Service
05/30/2026 - 3:55pm
Tulsa's Route 66 Capital Cruise Sets GUINNESS WORLD RECORDS™ Mark
05/30/2026 - 3:36pm
TTW Unveils Top 50 Coolcation Travel Destinations in the World for 2026
05/30/2026 - 2:43pm
Cyient Enters Agreement to Acquire TAO Digital
05/30/2026 - 2:30pm
Eikon Therapeutics Presents Data on Clinical-Stage Programs at the 2026 Annual Meeting of the American Society of Clinical Oncology
05/30/2026 - 2:30pm
Salubris Biotherapeutics Announces Updated Phase 1/2 Data for JK06, a 5T4-Targeted Antibody Drug Conjugate, at the 2026 American Society of Clinical Oncology Annual Meeting
05/30/2026 - 2:30pm
Orion Pharma announces first results from Phase 1/2 TEADES trial with TEAD inhibitor ODM-212 in patients with advanced solid tumours
05/30/2026 - 2:30pm
Whitehawk Therapeutics Presents Real‑World Analysis Confirming SEZ6 as a Highly Expressed, Clinically Relevant Target for SCLC and Other Neuroendocrine Tumors at ASCO 2026
05/30/2026 - 2:30pm
Precigen Presents New Long-Term Durability Data for PAPZIMEOS, Recently Granted Seven-Year Market Exclusivity, Demonstrating Complete Responses Beyond 4 Years
05/30/2026 - 2:15pm
Global Data for BioNTech and Bristol Myers Squibb's PD-L1xVEGF-A Bispecific Pumitamig Shows Encouraging Efficacy in Patients with Non-Small Cell Lung Cancer in ROSETTA Lung-02 Trial
05/30/2026 - 2:00pm
AI Sector Growth Accelerates Past $26 Billion as Ruvi AI (RUVI) Launches New Features, Proprietary Models, and Ecosystem Upgrades
05/30/2026 - 2:00pm
Ducks Unlimited Completes Historic $4.06 Billion Campaign
05/30/2026 - 1:52pm
Canada's Largest Street Cricket Fundraiser Raises $1.3 Million in Support of The Princess Margaret Cancer Foundation
05/30/2026 - 1:41pm
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages POET Technologies Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – POET